Showing 10,161 - 10,180 results of 101,398 for search '(( 5 ((a decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 0.98s Refine Results
  1. 10161
  2. 10162
  3. 10163
  4. 10164

    Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  5. 10165

    Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  6. 10166

    Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  7. 10167

    Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  8. 10168

    Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  9. 10169

    Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  10. 10170

    Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  11. 10171

    Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  12. 10172

    Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  13. 10173

    Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  14. 10174

    Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  15. 10175

    Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  16. 10176

    Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  17. 10177

    Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  18. 10178

    Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  19. 10179

    Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  20. 10180

    AdV-ZFP-VEGF administration reduces apoptosis after SCI. by Sarah A. Figley (389639)

    Published 2014
    “…There was a significant decrease in TUNEL-positive cells in the AdV-ZFP-VEGF treatment group versus all other injured groups (when compared against other groups and all distances). …”